Reduce the injection of subcutaneous low molecular weight heparin induced bleeding Methods and Experiences.doc
- 1、本文档共5页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Reduce the injection of subcutaneous low molecular weight heparin induced bleeding Methods and Experiences
PAGE \* MERGEFORMAT 5
Reduce the injection of subcutaneous low molecular weight heparin induced bleeding Methods and Experiences
[Keywords:] injection; low molecular weight heparin; subcutaneous hemorrhage
Low molecular weight heparin (LMWH) treatment of coronary syndrome clinical effect has been positive, because of abdominal subcutaneous injection of long duration, side effects have been widely used clinically. But because of its anticoagulant effect, injection press improper methods, and applications aspirin and other anticoagulant drugs in elderly patients synergies and factors such as vascular brittleness [1], can easily lead to subcutaneous injection site hemorrhage, manifested as skin petechia, ecchymosis, hematoma, local pain, increase patient pain, affecting the therapeutic effect. To this end the majority of nursing colleagues studied many methods for the prevention and treatment of subcutaneous hematoma, March 2008 -2009 adopted on March 51 cases of undergraduate subcutaneous low molecular weight heparin in coronary heart disease cases were observed, the author summarize the nursing experience, are as follows.
1 Clinical data
1.1 General information on the course of hospitalization of patients with coronary heart disease in 51 cases, 34 males and 17 females; age 36 to 76 years, mean 56.7 years, all of unstable angina. Platelet, coagulation test results were the normal range.
1.2 Operation Methods Techpool Biochemical Pharmaceutical Co., Ltd. production of low molecular weight heparin injection (specification 0.5ml: 5000AXaIU), is a manufacturer specialized syringe injection device supporting 1cm, the needle is about 1.2cm, around the U-shaped in the umbilical region within 5 ~ 10cm (except for Cullen 1cm) around the turn of subcutaneous injection. operation taut with his left thumb and index finger skin, right hand holding the syringe was slowly injected into the needle 40 (speed to 45 seconds is appropriate), body weight loss for ,
您可能关注的文档
- Reading Therapy Research.doc
- Ready intended off-season during the peak season.doc
- Real bonus release pattern channels- increased channel members.doc
- Real 'precision marketing'.doc
- Real break off-season Miju Fast Moving Consumer Goods.doc
- Real Confucian family - Management articles.doc
- Real estate 'European feeling' of the psychology of.doc
- Reagent and liquid nitrogen using TRIzol -k high quality total RNA extracted rat pancreas.doc
- Real estate ads- Like Fog Like Rain and Like Wind.doc
- Real Estate brand 'Deadly Secret'.doc
文档评论(0)